Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Infection-fighting bandages for serious burns

25.02.2016

EPFL helped develop a technology aimed at reducing the death rate among victims of serious burns

Serious burn victims are immunocompromised and may be missing skin on parts of their body, and this makes them highly vulnerable to bacteria. Thanks to progress in intensive care, they are decreasingly likely to die from burn trauma. Death is more commonly the result of infections that can occur several months after being hospitalized. The bandages used to treat burns actually represent a real breeding ground for microbes.


Infection-fighting bandage for the treatment of severe burns.

Credit: © Murielle Michetti

To combat these bacteria, which are increasingly antibiotic-resistant, a consortium of Swiss researchers worked on a biological bandage able to accelerate the scarring process and, ultimately, prevent bacteria from multiplying.

The researchers focused on the formidable bacterium called Pseudomonas aeruginosa, the main cause of infections and death among serious burn victims. An article describing the new bandage, which was developed in part at EPFL, has just been published in Scientific Reports.

The technology is based on a biodegradable bandage made of animal collagen and 'progenitor' cells that can multiply quickly. First developed by the CHUV in 2005, these bandages hastened the healing process but did nothing to protect against microbes.

The researchers have now demonstrated that by combining these biological bandages with special molecules called dendrimers, it would be possible to not only speed up healing but also to put a stop to infections.

Halting bacterial proliferation

The bandage consists of a strip of gauze made from collagen to which progenitor cells and dendrimers have been added. When the bandage is placed on a bacteria-infected site, some of the dendrimers migrate and destroy the microbes located in the direct vicinity of the bandage. Other dendrimers remain inside the bandage.

"Bandages are a favorable environment for bacterial growth," said Dominique Pioletti, the head of EPFL's Laboratory of Biomechanical Orthopedics. "So some dendrimers have to remain in the bandage to destroy any intruders." With his team, the researcher's task was to find a way to incorporate dendrimers in the biological bandage. He then observed how the bacteria interacted with the new bandage.

Cutting the death rate

For hospital burn specialists, this technology meets an urgent need. "Currently, we have to take enormous precautions with our patients," said Lee Ann Laurent-Applegate, the head of the Regenerative Therapy Unit at the CHUV. "The bandages, which sometimes cover most parts of the body, need to be changed every day for several months. Yet that does not stop infections. And we cannot prescribe antibiotics to all patients as a preventive measure for fear of making the bacteria more resistant. With the new bandages, rather than treating infections, we will be preventing them. We are nipping the problem in the bud."

The new bandage will be tested in Zurich before they can be used in clinics.

###

This study is part of a research platform sponsored by SwissTransMed and led by Lee Ann Laurent-Applegate, the head of the Regenerative Therapy Unit at the CHUV, and Wassim Raffoul, the head of Plastic and Hand Surgery at the CHUV.

The platform brings together leading Swiss institutions specializing in serious burns. It includes the CHUV Burn Center, the Burn Center at Zurich University Hospital, EPFL, the University of Lausanne, the University of Geneva, the Geneva University Hospitals and the University of Bern.

Each of the participants played a role in a key stage of the project reported on in Scientific Reports.

Article in Scientific Reports: Anti-Microbial Dendrimers against Multidrug-Resistant P. aeruginosa Enhance the Angiogenic Effect of Biological Burn-wound Bandages

Media Contact

Dominique Pioletti
dominique.pioletti@epfl.ch
41-216-938-341

 @EPFL_en

http://www.epfl.ch/index.en.html 

Dominique Pioletti | EurekAlert!

Further reports about: EPFL Polytechnique aeruginosa bandage infections microbes progenitor progenitor cells

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>